tricular systolic pressure rose to similar levels and this resulted in substantially higher peak aortic gradients with isoproterenol. A consistent correlation was observed for peak valvular gradients measured during exercise and isoproterenol in both groups of patients. Accordingly, regression equations were obtained allowing reasonably accurate prediction of exercise valvular gradients on the basis of the isoproterenol data.
micromanometer. The ventricular pressure tracing from the tip manometer was matched to a simultaneous pressure tracing obtained from the lumen fluid-filled system present in the same catheter and connected to a P23db Statham pressure transducer.
After information was recorded during rest, exercise data were obtained using a bicycle ergometer with a workload adjusted for each patient in order to increase the heart rate to approximately 150 beats/min, considered a mild level of exercise. The patients were exercised for a period of 11 to 14 min and all parameters recorded after a steady state was reached over a period of 4 to 5 min. Each child was then allowed to rest for a period of 20 min with return of the heart rate to normal as measured prior to exercise. A continuous intravenous isoproterenol infusion was then started at 1-2 mcg/m2/min, and titrated in each patient in order to achieve a level of heart rate as close as possible to that obtained during the exercise study. All parameters were recorded in a similar manner as during rest and exercise, after which the isoproterenol infusion was discontinued. Confirmatory evidence of isolated pulmonary or aortic valve stenosis was then obtained by angiocardiograms, and the catheterization studies were then terminated. Data obtained in the three states for each group of patients were averaged and compared statistically using the paired t test.
Results
In the patients with pulmonary stenosis, isoproterenol induced a greater increase in peak systolic gradient across the pulmonic valve as compared to exercise at equivalent heart rates ( fig. 1 , left panel). Right ventricular systolic pressure averaged 42 mm Hg at rest increasing to 64 mm Hg with exercise and 73 mm Hg during isoproterenol infusion. Peak systolic gradient increased from 24 mm Hg at rest, to 38 mm Hg with exercise and 52 mm Hg. with isoproterenol. Right ventricular dp/dt/p increased from an average of 28 sec ' at rest to 42 sec' with exercise and 55 sec-I with isoproterenol (table 1) during isoproterenol administration than with exercise, whereas left ventricular dp/dt/p rose to higher levels (table 2) .
Calculations of pulmonary and aortic valve area were obtained using the Gorlin formula. In eight of the 15 patients with pulmonary stenosis in whom the quality of the pressure tracings allowed calculations of the pulmonary valve area in the three hemodynamic states, averaged values of cardiac in-dex were lower and mean systolic gradient higher with isoproterenol as compared to exercise (table 3) . This resulted in a smaller calculated valve area index with isoproterenol (1.33 cm2/m2) as compared to exercise (1.60 cm2/m2) (P < 0.01) (table 3) . A smaller pulmonary valve area was also calculated with isoproterenol as compared to resting conditions (table 3) .
In the eight patients with aortic stenosis, the averaged calculated aortic valve area was significantly smaller with isoproterenol (0.79 cm2/m2) as compared to exercise (1.04 cm2/m2) (table 4) . Higher values of mean systolic gradient (table 4) and lower values of cardiac index (table 2) with isoproterenol as compared to exercise caused this difference. The greater increase in mean systolic gradient as compared to the increment in cardiac index obtained with Abbreviations: R = rest; E = exercise; I = isoproterenol; HR = heart rate; RVSP right ventricular systolic pressure; PASP = pulmonary artery systolic pressure; PSG = peak systolic gradient; RVEDP = right ventricular end-diastolic pressure; PA = mean pulmonary arterial pressure; BA = mean brachial artery pressure; CI = cardiac index; PRI = pulmonary resistance index; SRI = systemic resistance index; RV dp/dt/p = right ventricular dp/dt/p. pressure; CI = cardiac index; SRI = systemic resistance index; PRI = pulmonary resistance index; LV dp/dt/p = left ventricular dp/dt/p. Abbreviations: R = rest; E = exercise; I = isoproterenol; HR = heart rate; SET = systolic ejection time; CI = cardiac index; MSG = meaM systolic gradient; PVAI = pulmonary valve area index.
isoproterenol as compared to resting conditions resulted in a smaller calculated aortic valve area with this pharmacological agent (table 4) .
Linear regression equations were derived in both groups of patients in order to predict the peak systolic gradient (PSG) with exercise (E) on the basis of measurements obtained during isoproterenol (I) administration (figs. 2 and 3). Although the peak systolic gradients were greater with isoproterenol, the correlation was consistent, as shown by the proximity of individual values to the regression line, allowing close estimation of exercise gradient based on the measurements obtained during isoproterenol administration. Utilizing these regression equations, pulmonary and aortic valve gradients could be predicted with 95% accuracy, to within + 10 mm Hg for pulmonary stenosis and + 12 mm Hg for aortic stenosis.
Discussion
Previous studies have stated that isoproterenol infusion during cardiac catheterization provides a satisfactory method of simulating exercise conditions in pediatric patients with pulmonary or aortic valve stenosis." 3 The reports have included measurements at rest and during isoproterenol infusion but no exercise data was obtained in the same patients. A recent study by Neal et al.,2 including hemodynamic observations at rest, exercise and isoproterenol in children with pulmonary valve stenosis, showed that isoproterenol increases the pulmonary valve gradient out of proportion to the increase in cardiac output as compared to exercise. These authors concluded that the severity of pulmonary valve stenosis will be overestimated if only the resting and isoproterenol measurements are used. In the present study of children with pulmonary stenosis or aortic stenosis, left or right ventricular systolic pressure was slightly higher with isoproterenol as compared to exercise and pulmonary and systemic arterial systolic pressures were lower during isoproterenol infusion. This resulted in significantly higher peak systolic gradients with isoproterenol. The effects of heart rate were eliminated by matching heart rate during isoproterenol administration and exercise in both groups of patients. Even though a period of 20 minutes was allowed upon completion of exercise in both groups of patients, with return of heart rate to resting values before the initiation of isoproterenol infusion, a potential source of error can not be completely ruled out by using this nonrandomized sequence of interventions.
The previous observation by Neal and co-workers2 showed that the calculated pulmonary valve area was significantly smaller with isoproterenol when compared to exercise and resting conditions. As these authors pointed out, it is unlikely that the orifice of the pulmonary valve changes in size during exercise or isoproterenol administration, and that the higher values of systolic gradients obtained with isoproterenol are most likely related to some degree of infundibular obstruction induced by this agent. This phenomena of subvalvular obstruction was probably also present in the group of patients with aortic valve stenosis, resulting in significantly higher aortic systolic gradients with 100- isoproterenol as compared to exercise despite greater increment in cardiac output obtained during exertion. Although isoproterenol and exercise both induced an increase in cardiac output and a decrease in systemic vascular resistance, the magnitude of changes in those parameters was different in the two states. The greater increase in cardiac output with exercise can be explained on the bases of metabolic vasodilation in the active muscles decreasing systemic resistance while constriction of the systemic veins and the pumping action of the skeletal muscles increases the venous return to the heart.7' 8 In addition, the potent vasodilator effect of isoproterenol may have contributed to the lower values of systemic arterial pressure obtained with this agent.
The increase in ventricular systolic pressures obtained with mild exercise in our patients was most likely related to an increase in preload as well as an increase in myocardial contractility.
Our data in patients with pulmonary stenosis are in general agreement with the observations of Neal et al. regarding the increase in peak valvular gradient with isoproterenol out of proportion with the increase in cardiac output as compared to exercise. However, despite the differences in mechanisms causing increased semilunar gradients, the effects of exercise and isoproterenol were fairly consistent in patients with pulmonary or aortic valve stenosis at similar increments of heart rate. Individual values fit well to the regression line in both groups of patients (figs. 2 and 3). Thus, the linear regression equations generated from these data can be used to estimate gradients of the stenotic lesion under exercise conditions at an equivalent heart rate.
We believe that exercise studies remain the method of choice for the complete evaluation of patients with aortic or pulmonary stenosis. However, isoproterenol infusion and application of these regression equations constitute a practical and useful alternative when exercise studies cannot be carried out. surrounding the conduction system have led to fibrosis and death from heart block. Antinuclear antibodies of the IgG class cross the placental barrier and newborn infants have been reported with transient skin lesions of lupus. Placental transmission of such antibodies may affect the fetal cardiac conduction system, surrounding collagen, and myocardium, leading in some cases to CCHB. This is probably one important etiologic factor in CCHB even though the mother is asymptomatic during her pregnancy.
cooperative study of the European and American Pediatric Cardiologists in 1972,7 presenting the results of studies on 599 infants and children, provided a clearer picture of the clinical aspects of congenital complete heart block. There were 14 families with two siblings with heart block and two families with three siblings, but no maternal history is given and the etiology of this rare condition remained obscure.
A coincidence of observing several cases of congenital heart block within a few months at the Medical College of Virginia prompted a review of the clinical findings in all children with congenital heart block seen at the Medical College of Virginia during the preceding 12 years. Since a CI RCULATION
